Fulgent Genetics, Inc. (FLGT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 808.51M |
| Enterprise Value | 766M |
| P/E Ratio | -6.94 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 1.66 |
| Price/Book Ratio | 0.55 |
| Enterprise/Revenue | 1.61 |
| Enterprise/EBITDA | -8.03 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.26 |
| Operating Margin | -0.37 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.08 |
Income Statement
| Revenue | 322.67M |
| Revenue/Share | 11.57 |
| Gross Profit | 130.88M |
| EBITDA | -45.83M |
| Net Income | -60.51M |
| Diluted EPS | -1.97 |
Balance Sheet
| Total Cash | 257.03M |
| Total Cash/Share | 9.18 |
| Total Debt | 9.42M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 6.34 |
| Book Value Per Share | 35.56 |
Price History
| 52-Week Change | -16.68 |
| 52-Week High | 31.04 |
| 52-Week Low | 13.46 |
| Moving Average 50 Days | 20.53 |
| Moving Average 200 Days | 19.62 |
Statistics
| Average Volume | 301,993 |
| Shares Outstanding | 27.52M |
| % Held by Institutions | 51.97 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
